156 related articles for article (PubMed ID: 9217665)
1. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis.
Wang G; Hansen H; Tatsis E; Csernok E; Lemke H; Gross WL
Am J Med; 1997 Jun; 102(6):517-23. PubMed ID: 9217665
[TBL] [Abstract][Full Text] [Related]
2. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides.
Schönermarck U; Csernok E; Trabandt A; Hansen H; Gross WL
Clin Exp Rheumatol; 2000; 18(4):457-63. PubMed ID: 10949720
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity.
Schmitt WH; Heesen C; Csernok E; Rautmann A; Gross WL
Arthritis Rheum; 1992 Sep; 35(9):1088-96. PubMed ID: 1418025
[TBL] [Abstract][Full Text] [Related]
4. Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy.
Holmlund U; Bengtsson A; Nilsson C; Kusoffsky E; Lilja G; Scheynius A; Sverremark-Ekström E
Clin Exp Allergy; 2003 Nov; 33(11):1531-6. PubMed ID: 14616865
[TBL] [Abstract][Full Text] [Related]
5. Serum markers of T cell activation in relapses of Wegener's granulomatosis.
Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
Clin Exp Immunol; 1993 Mar; 91(3):415-20. PubMed ID: 8443965
[TBL] [Abstract][Full Text] [Related]
6. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis.
Ulusoy H; Kamanli A; Ilhan N; Kuru O; Arslan S; Alkan G; Ozgocmen S
Rheumatol Int; 2012 Dec; 32(12):3857-62. PubMed ID: 22193227
[TBL] [Abstract][Full Text] [Related]
8. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy.
Gerli R; Bistoni O; Lunardi C; Giacomelli R; Tomassini C; Biagini P; Pitzalis C
Rheumatology (Oxford); 1999 Dec; 38(12):1282-4. PubMed ID: 10587561
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
[TBL] [Abstract][Full Text] [Related]
12. CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role.
Gerli R; Pitzalis C; Bistoni O; Falini B; Costantini V; Russano A; Lunardi C
J Immunol; 2000 Apr; 164(8):4399-407. PubMed ID: 10754341
[TBL] [Abstract][Full Text] [Related]
13. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.
Lamprecht P; Moosig F; Gause A; Herlyn K; Csernok E; Hansen H; Gross WL
Ann Rheum Dis; 2001 Apr; 60(4):385-90. PubMed ID: 11247870
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of soluble CD30 in chronic hepatitis B virus infection.
Fattovich G; Vinante F; Giustina G; Morosato L; Alberti A; Ruol A; Pizzolo G
Clin Exp Immunol; 1996 Jan; 103(1):105-10. PubMed ID: 8565268
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone.
Barbano G; Cappa F; Prigione I; Pistoia V; Cohen A; Chiesa S; Gusmano R; Perfumo F
Nephrol Dial Transplant; 2001 Sep; 16(9):1807-13. PubMed ID: 11522862
[TBL] [Abstract][Full Text] [Related]
16. Plasma-soluble CD30 in childhood tuberculosis: effects of disease severity, nutritional status, and vitamin A therapy.
Hanekom WA; Hussey GD; Hughes EJ; Potgieter S; Yogev R; Check IJ
Clin Diagn Lab Immunol; 1999 Mar; 6(2):204-8. PubMed ID: 10066655
[TBL] [Abstract][Full Text] [Related]
17. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
Brouwer E; Stegeman CA; Huitema MG; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909
[TBL] [Abstract][Full Text] [Related]
18. Monocyte activation in patients with Wegener's granulomatosis.
Muller Kobold AC; Kallenberg CG; Tervaert JW
Ann Rheum Dis; 1999 Apr; 58(4):237-45. PubMed ID: 10364903
[TBL] [Abstract][Full Text] [Related]
19. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis.
Abdulahad WH; van der Geld YM; Stegeman CA; Kallenberg CG
Kidney Int; 2006 Sep; 70(5):938-47. PubMed ID: 16837919
[TBL] [Abstract][Full Text] [Related]
20. T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30).
De Pitá O; Frezzolini A; Cianchini G; Ruffelli M; Teofoli P; Puddu P
Arch Dermatol Res; 1997 Nov; 289(12):667-70. PubMed ID: 9452886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
